S
S. Stoker
Researcher at Intermountain Medical Center
Publications - 19
Citations - 578
S. Stoker is an academic researcher from Intermountain Medical Center. The author has contributed to research in topics: Ventricular assist device & Survival rate. The author has an hindex of 8, co-authored 19 publications receiving 527 citations. Previous affiliations of S. Stoker include Primary Children's Hospital.
Papers
More filters
Journal ArticleDOI
Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure: Insights Into Cardiac Recovery
Stavros G. Drakos,Stavros G. Drakos,Omar Wever-Pinzon,Craig H. Selzman,Craig H. Selzman,Edward M. Gilbert,Rami Alharethi,Bruce B. Reid,Abdulfattah Saidi,Nikolaos A. Diakos,S. Stoker,Erin Davis,Matthew A. Movsesian,Dean Y. Li,Josef Stehlik,Abdallah G. Kfoury,Ucar Investigators +16 more
TL;DR: Continuous-flow LVAD unloading induced in a subset of patients, both ischemic and nonischemic, early improvement in myocardial structure and systolic and diastolic function that was largely completed within 6 months, with no evidence of subsequent regression.
Journal ArticleDOI
End-of-life decision making and implementation in recipients of a destination left ventricular assist device
Sally Brush,Deborah Budge,Rami Alharethi,Ashley J. McCormick,Jane E. MacPherson,Bruce B. Reid,I.D. Ledford,H.K. Smith,S. Stoker,Stephen E. Clayson,John R. Doty,William T. Caine,Stavros G. Drakos,Abdallah G. Kfoury +13 more
TL;DR: A multidisciplinary team approach with protocols involving DT patients and their families in EOL decision making allows for continuity of care and ensures dignity and comfort at EOL.
Journal ArticleDOI
Obesity and left ventricular assist device driveline exit site infection
Ashley L. Raymond,Abdallah G. Kfoury,Corey J. Bishop,Erin Davis,Kimberly M. Goebel,S. Stoker,Craig H. Selzman,Stephen E. Clayson,H.K. Smith,Cris G. Cowley,Rami Alharethi,Deborah Budge,Bruce B. Reid +12 more
TL;DR: Results may warrant increased measures to prevent and treat infection in the preimplant and postimplant periods, and implications for clinical practice may include the provision of nutrition and exercise counseling for patients undergoing LVAD therapy, especially if overweight.
Journal ArticleDOI
Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
Stavros G. Drakos,Abdallah G. Kfoury,Abdallah G. Kfoury,Abdallah G. Kfoury,John R. Kotter,Bruce B. Reid,Bruce B. Reid,Bruce B. Reid,Stephen E. Clayson,Stephen E. Clayson,Stephen E. Clayson,Craig H. Selzman,Craig H. Selzman,Craig H. Selzman,Josef Stehlik,Josef Stehlik,Josef Stehlik,Patrick W. Fisher,Patrick W. Fisher,Patrick W. Fisher,Mario Merida,David D. Eckels,Kim Brunisholz,Kim Brunisholz,Kim Brunisholz,Benjamin D. Horne,S. Stoker,Dean Y. Li,Dean Y. Li,Dale G. Renlund +29 more
TL;DR: Pre-sensitized patients are at higher risk for becoming and remaining highly HLA-allosensitized after LVAD implantation, and the HeartMates II LVAD appears to cause less sensitization than HeartMate I.
Journal ArticleDOI
A novel non-invasive method to assess aortic valve opening in HeartMate II left ventricular assist device patients using a modified Karhunen-Loève transformation
Corey J. Bishop,N.O. Mason,Abdallah G. Kfoury,Robert L. Lux,S. Stoker,Kenneth Horton,Stephen E. Clayson,B.Y. Rasmusson,Bruce B. Reid +8 more
TL;DR: Constant regulation and optimization of rotary non-pulsatile LVADs would minimize patients' risk for neurologic events and aortic valve stenosis and develop a physiologic feedback algorithm for an auto-mode, which currently does not exist.